Established and suspected risk factors in breast cancer aetiology

Breast Care

Volumn 4, Issue 2, 2009, Pages 82-87

  Kluttig, Alexander ^a   Schmidt Pokrzywniak, Andrea ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Breast cancer; Epidemiology; Risk factor

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTRADIOL; GESTAGEN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; TESTOSTERONE;

ALCOHOL CONSUMPTION; BODY HEIGHT; BODY MASS; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; DIET; DISEASE ASSOCIATION; ELECTROMAGNETIC FIELD; ETHNICITY; FAMILY HISTORY; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MENARCHE; MENOPAUSE; MIGRATION; OBESITY; PARITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SMOKING;

EID: 67649202487     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000211368     Document Type: Review

References (53)

1. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 5, version 2.0. Lyon, IARC Press, 2004.
2. Boyle P, Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488.
3. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller AB, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK: SEER Cancer Statistics Review, 1975-2005, National Cancer Institute, Bethesda, MD. http://seer cancer gov/csr/1975-2005/.
4. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. Lyon, IARC Press, 2001.
5. Morris GJ, Mitchell EP: Higher incidence of aggressive breast cancers in African-American women: a review. J Natl Med Assoc 2008;100:698-702.
6. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, et al.: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-1827.
7. Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS: Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology 1995;6:181-183.
8. Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-1399.
9. Turnbull C, Rahman N: Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 2008;9:321-345.
10. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
11. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792.
12. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, et al.: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72:1117-1130.
13. The CHEK2 Breast Cancer Case-Control Consortium: CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004;74:1175-1182.
14. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF: Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 2005;97:813-822.
15. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-1093.
16. Bernstein L: Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 2002;7:3-15.
17. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350:1047-1059.
18. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD: Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
19. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-236.
20. Martin LJ, Boyd NF: Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008;10:201.
21. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, et al.: Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-527.
22. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI: Growth patterns and the risk of breast cancer in women. N Engl J Med 2004;351:1619-1626.
23. Trichopoulos D, Lagiou P, Adami HO: Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 2005;7:13-17.
24. Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-616.
25. Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K: Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a metaanalysis of literature. Int J Cancer 2004;111:293-297.
26. Schnitt SJ: Benign breast disease and breast cancer risk: potential role for antiestrogens. Clin Cancer Res 2001;7:4419s-4422s.
27. Ashbeck EL, Rosenberg RD, Stauber PM, Key CR: enign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:467-472.
28. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB: Diet and breast cancer: a review of the prospective observational studies. Cancer 2007;109:2712-2749.
29. Smith-Warner SA, Spiegelman D, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, et al.: Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 2001;92:767-774.
30. Trock BJ, Hilakivi-Clarke L, Clarke R: Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-471.
31. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, et al.: Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 2001;285:769-776.
32. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, Jr, Coates RJ, Liff JM, Talamini R, Chantarakul N, et al.: Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002;87:1234-1245.
33. World Cancer Research Fund / American Institute for Cancer Research: Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, D.C., AICR, 2007.
34. Seitz HK, Becker P: Alcohol metabolism and cancer risk. Alcohol Res Health 2007;30:38-41, 44-47.
35. Band PR, Le ND, Fang R, Deschamps M: Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002;360:1044-1049.
36. Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J: Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:15-26.
37. Pirie K, Beral V, Peto R, Roddam A, Reeves G, Green J: Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 2008;37:1069-1079.
38. Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, van Leeuwen FE: Physical activity and breast cancer: a systematic review. Epidemiology 2007;18:137-157.
39. Harvie M, Hooper L, Howell AD: Central obesity and breast cancer risk: a systematic review. Obes Rev 2003;4:157-173.
40. Feigelson HS, Patel AV, Teras LR, Gansler T, Thun MJ, Calle EE: Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer 2006;107:12-21.
41. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE: Adult weight change and risk of postmenopausal breast cancer. JAMA 2006;296:193-201.
42. Ewertz M, Duffy SW, Adami HO, Kvale G, Lund E, Meirik O, Mellemgaard A, Soini I, Tulinius H: Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer 1990;46:597-603.
43. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187-195.
44. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, et al.: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003;289:3243-3253.
45. Collins JA, Blake JM, Crosignani PG: Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update 2005;11:545-560.
46. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA: The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670-1674.
47. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-1727.
48. Ronckers CM, Erdmann CA, Land CE: Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005;7:21-32.
49. Feychting M, Forssen U: Electromagnetic fields and female breast cancer. Cancer Causes Control 2006;17:553-558.
50. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, et al.: Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006;98:1204-1214.
51. Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA: Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 2008;168: 404-411.
52. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, et al.: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679.
53. Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN: Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008;15:239-246.